학술논문

Malassezia Is Associated with Crohn’s Disease and Exacerbates Colitis in Mouse Models
Document Type
article
Source
Cell Host & Microbe. 25(3)
Subject
Microbiology
Biological Sciences
Biomedical and Clinical Sciences
Digestive Diseases
Crohn's Disease
Autoimmune Disease
Inflammatory Bowel Disease
Prevention
2.1 Biological and endogenous factors
Aetiology
Inflammatory and immune system
Oral and gastrointestinal
Animals
CARD Signaling Adaptor Proteins
Colitis
Crohn Disease
Cytokines
Disease Models
Animal
Gastrointestinal Tract
Malassezia
Mice
CARD9
Crohn disease
c-type lectin
mycobiome
Medical Microbiology
Immunology
Biochemistry and cell biology
Medical microbiology
Language
Abstract
Inflammatory bowel disease (IBD) is characterized by alterations in the intestinal microbiota and altered immune responses to gut microbiota. Evidence is accumulating that IBD is influenced by not only commensal bacteria but also commensal fungi. We characterized fungi directly associated with the intestinal mucosa in healthy people and Crohn's disease patients and identified fungi specifically abundant in patients. One of these, the common skin resident fungus Malassezia restricta, is also linked to the presence of an IBD-associated polymorphism in the gene for CARD9, a signaling adaptor important for anti-fungal defense. M. restricta elicits innate inflammatory responses largely through CARD9 and is recognized by Crohn's disease patient anti-fungal antibodies. This yeast elicits strong inflammatory cytokine production from innate cells harboring the IBD-linked polymorphism in CARD9 and exacerbates colitis via CARD9 in mouse models of disease. Collectively, these results suggest that targeting specific commensal fungi may be a therapeutic strategy for IBD.